Search

everythinglearnresearchcommunity

for

Search:↓

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

BST2 protein and certain T cells increase in early alopecia areata.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Cells that move well may improve hair loss treatments by entering hair follicles.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.